37 C.F.R. § 1.183
Suspension of rules
In an extraordinary situation, when justice requires, any requirement of the regulations in this part which is not a requirement of the statutes may be suspended or waived by the Director or the Director's designee, sua sponte, or on petition of the interested party, subject to such other requirements as may be imposed. Any petition under this section must be accompanied by the petition fee set forth in § 1.17(f).
Notes of Decisions
Cited in 35
cases (2 in the last 5 years), 1959–2022 · leading case: Target Training International, Ltd. v. Lee
Target Training International, Ltd. v. Lee (2014)
“” See 37 C.F.R. § 1.183 . The Director argues that a decision pursuant to this rule falls within the exception to judicial review for a decision “committed to agency discretion by law” in 5 U.”
Helfgott & Karas, P.C., and Dov Sheffer and R.S.R. Adtec Ltd. v. Q. Todd Dickenson, Director of the United States Patent (2000)
“Helfgott then wrote a letter in early October 1997 to the Assistant Commissioner of Patents, asking him “to look into the matter in the interests of justice and equity” pursuant to 37 C.F.R. § 1.183 , which allows the Commissioner to suspend nonstatutory rules “in an…”
Nippon Shinyaku Co. v. Iancu (2019)
“…index="43" url="https://cite.case.law/citations/?q=37%20C.F.R.%20%C2%A7%201.183"> 37 C.F.R. § 1.183 (2013). Finally, the patent applicant may seek judicial review in federal district court. <span cl”
Burandt v. Dudas (2008)
“Burandt filed a petition under 37 C.F.R. § 1.183 , which provides that: In an extraordinary situation, when justice requires, any requirement of the regulations in this part which is.”
Stephen Wyden v. Commissioner of Patents and Trademarks (1986)
“Those sections are also the authorization for the Commissioner's promulgation of regulations, which are found in 37 CFR, pertaining to "the recognition and conduct of agents, attorneys, or other persons representing applicants or other parties before the Patent and Trademark…”
Baxter International, Inc., and Baxter Healthcare Corporation v. McGaw Inc., Defendant-Cross (1998)
“' Baxter next argues that the PTO nonetheless had the discretion to suspend its regulations, sua sponte, in the interests of justice under 37 C.F.R. § 1.183 . Section 1.183 provides in relevant part: “In an extraordinary situation, when justice requires, a requirement of the…”
Carotek, Inc. v. Kobayashi Ventures, LLC (2012)
“11, Petition Under 37 CFR § 1.183 Suspension of Rules (the “Petition”).”
StairMaster Sports/Medical Products, Inc. v. Groupe Procycle, Inc. (1998)
“Additionally, StairMaster maintains Procycle has cited no authority that the PTO is precluded from implicitly waiving any *289 perceived deficiencies in the supplemental declarations to the reissue application under 37 C.F.R. § 1.183 . 16 Lastly, StairMaster argues that certain…”
Margolis v. Banner (1979)
“] The portion of the petition relating to 37 CFR 1.183, which was a request to waive 37 CFR 1.”
In Re Michael Ben Graves (1995)
“See 37 C.F.R. § 1.183 (in an extraordinary situation, the Commissioner may suspend or waive any requirement of the rules not required by statute); Eckey v.”
Daiichi Sankyo Company, Limited v. Kappos (2013)
“…or the Director’s designee” “[i]n an extraordinary situation, when justice requires.” 37 C.F.R. § 1.183 (2013). II. FACTUAL BACKGROUND Daiichi is the assignee of the ’205, ’014, and 135 patents.2d Am. Compl. ¶ 8. Patent Application Serial No. 10/481,262 issued as the ’205…”
Tafas v. Dudas (2008)
“37 C.F.R. § 1.183 (2006). The 2 + 1 Rule also applies retroactively to patent applications already filed before the effective date of the Final Rules.”
Earth Resources Corp. v. United States (1999)
“ERC’s petition also included a petition under 37 C.F.R. § 1.183 5 to waive the requirement that all parties consent to a petition under 37 C.”
Ariad Pharm., Inc. v. Matal (2018)
“…index="16" url="https://cite.case.law/citations/?q=37%20C.F.R.%20%C2%A7%201.183"> 37 C.F.R. § 1.183 . II. 1 Plaintiff in this case, ARIAD Pharmaceuticals ("ARIAD"), is a Delaware corporation and the owner of the United States Patent No.”
Enzo Therapeutics, Inc. v. Yeda Research & Development Co. (2007)
“137(b)(4), Enzo filed a “Petition Under 37 C.F.R. § 1.183 to Request Waiver of the Requirement for Filing a Terminal Disclaimer” (“Petition for Waiver”).”
Commonwealth of Australia v. Radio Corporation of America (1968)
“37 C.F.R. § 1.183 . *811 This was a proper exercise of the Commissioner’s power for it has been held that his power to suspend requirements of the Patent Office Rules when justice requires may be exercised to suspend or waive the sixty day limit of Rule 304, Eckey v.”
Harold T. Klein v. The Commissioner of Patents of the United States (1973)
“Appellants then petitioned the Commissioner in person, pursuant to 37 CFR § 1.183 . 2 The Commissioner refused to invoke the provisions of § 1.”
Daiichi Sankyo Company v. Lee (2015)
“705 (d), Daiichi concurrently filed a petition to waive the two-month window under 37 C.F.R. § 1.183 . Section 1.183 allows the Director, on petition, to waive regulatory requirements in “extraordinary situations” when justice so requires.”
Eddy W. Eckey v. Robert C. Watson, Commissioner of Patents (1959)
“” 37 C.F.R. § 1.183 (1949). We think the sixty-day provision iir Section 304 of the Rules, made pursuant to the authority given the Commissioner by Section 145 to “appoint” the time for bringing suit, is not a “requirement of' the statutes” within the meaning of Rule 183.”
Dresser Industries, Inc. v. Ford Motor Co. (1981)
“3 In such cases, the PTO will also entertain petitions under 37 C.F.R. § 1.183 to waive the two-month delay period provided by 37 C.”
U. S. Department of Energy v. White (1981)
“That option lies only with the Commissioner under 37 CFR 1.183. Aside from such waiver, the rules provide a remedy by way of a “prompt” motion under 37 CFR 1.”
Sampson v. Dann (1978)
“” does not seek a suspension or waiver of any regulation under 37 CFR 1.183, it is being treated merely as a request for information concerning the withdrawal of the application from issue.”
Urologix, Inc. v. PROSTALUND AB (2002)
“Urologix cites to 37 C.F.R. § 1.183 , which states, In an extraordinary situation, when justice requires, any requirement of the regulations in this part which is not a requirement of the statutes may be sus *1039 pended or waived by the Commissioner or the Commissioner’s…”
Helfgott & Karas, P.C. v. Lehman (1998)
“37 C.F.R. § 1.183 The PTO rejected plaintiffs Petition to correct the Demand as untimely under 37 C.”
Mobil Oil Corp. v. Dann (1976)
“The company applied to the Commissioner because he alone had the power under Rule 183 of the Rules of Practice in Patent Cases, 37 C.F.R. § 1.183 (1975), to suspend the sixty-day filing requirement.”
Kim v. Quigg (1989)
“137 (a) for unavoidable delay and another pursuant to 37 C.F.R. § 1.183 to suspend the one year filing period requirement of 37 C.”
Exxon Corp. v. Phillips Petroleum (1999)
“While 37 C.F.R. § 1.183 provides that “[i]n an extraordinary situation, when justice requires, a requirement of the regulations in this part which is not a requirement of the statutes may be suspended or waived by the Commissioner .”
Enzo Therapeutics, Inc. v. Yeda Research & Development Co. of the Weizmann Institute of Science (2006)
“On April 12, 2006, Enzo filed a Petition Under 37 C.F.R. § 1.183 with the Board requesting that the Director instruct the Board to withdraw its decision on the Motion for Benefit and have the Deputy Commissioner first decide the Petition to Revive (“183 Petition”) — the same…”
Land O'Lakes Creameries, Inc. v. Oconomowoc Canning Co. (1961)
“1959), wherein this question was specifically raised, holds that the sixty day provision of Rule 304 was not a requirement of the statutes within the meaning of Patent Practice Rule 183, 37 C.F.R. § 1.183 , which is similar to Trade-mark Practice Rule 2.”
Nippon Shinyaku Co., Ltd. v. Kappos (2019)
“…Director’s designee” in “an extraordinary situation, when justice requires[.]” 37 C.F.R. § 1.183 (2013). Finally, the patent applicant may seek judicial review in federal district court. 35 U.S.C. § 154 (b)(4)(A). At the time that Nippon’s p”
GENETICS & IVF INSTITUTE v. Kappos (2011)
“182 , stating that “[a]ll situations not specifically provided for in the regulations of this part will be decided in accordance with the merits of each situation,” and 37 C.F.R. § 1.183 , stating that “[i]n an extraordinary situation, when justice requires, any requirement of…”
Mobil Oil Corp. v. Dann (1978)
“On October 27, 1976, this Court issued a Memorandum and Order remanding this case back to the United States Patent and Trademark Office for a reconsideration of plaintiff Mobil Oil Corporation’s petition for relief under 37 C.F.R. § 1.183 . See Mobil Oil Corporation v.”
Virnetx Inc. v. Cisco Systems, Inc. (2020)
“Cisco is left to argue that, under 37 C.F.R. § 1.183 , the Director can in extraordinary circumstances sua sponte waive requirements of the regu- lations that are not required by the statutes.”
In Re VIVINT, INC. (2021)
“§§ 301–07 (governing ex parte reexamination); 37 C.F.R. § 1.183 (allowing for waiver of Patent Office rules).”
Pavlov v. Hirshfeld (2022)
“…a requirement of the statutes may be suspended or waived by the Director... .” 37 C.F.R. § 1.183 . 8 Without the preliminary injunction, plaintiffs would not have been able to proceed into the “national phase” on time and their application would have been precluded from being…”
Annotations are extracted automatically from the opinions in the
Syfert caselaw corpus and ranked by authority, recency, and
treatment. Dots show Syfertize treatment of the citing case itself.